المؤلفون: Conteduca V; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Wetterskog D; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Sharabiani MTA; Research Data Management and Statistics Unit, The Royal Marsden NHS Foundation Trust, London, UK., Grande E; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid., Fernandez-Perez MP; Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia, Murcia., Jayaram A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK., Salvi S; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Romanel A; Centre for Integrative Biology, University of Trento, Trento, Italy., Lolli C; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Casadio V; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Gurioli G; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Amadori D; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Font A; Oncology Unit, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona., Vazquez-Estevez S; Department of Medical Oncology, H. Universitario Lucus Augusti, Lugo., González Del Alba A; Department of Medical Oncology, H.U. Son Espases Mallorca, Mallorca., Mellado B; Department of Medical Oncology, IDIBAPS Hospital Clinic, Barcelona., Fernandez-Calvo O; Department of Medical Oncology, Hospital de Orense, Orense., Méndez-Vidal MJ; Department of Medical Oncology, Hospital Universitario Reina Sofía, Córdoba., Climent MA; Department of Medical Oncology, Instituto Valenciano de Oncología Valencia, Valencia., Duran I; Department of Medical Oncology, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla., Gallardo E; Department of Medical Oncology, H.U. Parc Taulí, Sabadell, Barcelona., Rodriguez A; Department of Medical Oncology, Hospital de León, León., Santander C; Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza., Sáez MI; Department of Medical Oncology, Hospital Regional y Hospital Virgen de la Victoria, Malaga., Puente J; Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Gasi Tandefelt D; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Wingate A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Dearnaley D; Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Demichelis F; Centre for Integrative Biology, University of Trento, Trento, Italy.; Institute for Precision Medicine, Weill Cornell Medicine, New York, USA., De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Gonzalez-Billalabeitia E; Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia, Murcia.; Department of Medical Oncology, Universidad Católica San Antonio de Murcia-UCAM, Murcia, Spain., Attard G; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.

مؤلفون مشاركون: PREMIERE Collaborators, Spanish Oncology Genitourinary Group

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Jul 01; Vol. 28 (7), pp. 1508-1516.

نوع المنشور: Clinical Trial; Comparative Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Androstenes/*therapeutic use , Antineoplastic Agents, Hormonal/*therapeutic use , Biomarkers, Tumor/*blood , Circulating Tumor DNA/*blood , Phenylthiohydantoin/*analogs & derivatives , Prostatic Neoplasms, Castration-Resistant/*blood , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Receptors, Androgen/*blood, Adult ; Aged ; Aged, 80 and over ; Androstenes/adverse effects ; Antineoplastic Agents, Hormonal/adverse effects ; Benzamides ; Biomarkers, Tumor/genetics ; Circulating Tumor DNA/genetics ; DNA Mutational Analysis ; Disease Progression ; Disease-Free Survival ; Europe ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multiplex Polymerase Chain Reaction ; Multivariate Analysis ; Mutation ; Nitriles ; Odds Ratio ; Patient Selection ; Phenylthiohydantoin/adverse effects ; Phenylthiohydantoin/therapeutic use ; Precision Medicine ; Predictive Value of Tests ; Proportional Hazards Models ; Prospective Studies ; Prostatic Neoplasms, Castration-Resistant/genetics ; Prostatic Neoplasms, Castration-Resistant/mortality ; Receptors, Androgen/genetics ; Risk Factors ; Time Factors ; Treatment Outcome

المؤلفون: Joan Carles, Teresa Alonso-Gordoa, Begoña Mellado, María J. Méndez-Vidal, Sergio Vázquez, Aránzazu González-del-Alba, Josep M. Piulats, Pablo Borrega, Enrique Gallardo, Rafael Morales-Barrera, Pilar Paredes, Oscar Reig, Carmen Garcías de España, Ricardo Collado, Teresa Bonfill, Cristina Suárez, Miguel Sampayo-Cordero, Andrea Malfettone, Javier Garde

المساهمون: Institut Català de la Salut, [Carles J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Alonso-Gordoa T] Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Mellado B] Medical Oncology Department, Hospital Clínic Barcelona, Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. [Méndez-Vidal MJ] Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain. Reina Sofía University Hospital (HURS), Córdoba, Spain. [Vázquez S] Lucus Augusti University Hospital, Lugo, Spain. [González-del-Alba A] Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain. [Morales-Barrera R] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Male, Cancer Research, Antiandrògens - Ús terapèutic, Hormones, Hormone Substitutes, and Hormone Antagonists::Hormone Antagonists::Androgen Antagonists [CHEMICALS AND DRUGS], Abiraterone Acetate, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Androgen Antagonists, Bone Neoplasms, Pròstata - Càncer - Tractament, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms::Prostatic Neoplasms, Castration-Resistant [DISEASES], Prostatic Neoplasms, Castration-Resistant, hormonas, sustitutos de hormonas y antagonistas de hormonas::antagonistas de hormonas::antagonistas de andrógenos [COMPUESTOS QUÍMICOS Y DROGAS], Oncology, Receptors, Androgen, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata::neoplasias prostáticas resistentes a la castración [ENFERMEDADES], Benzamides, Nitriles, Phenylthiohydantoin, Avaluació de resultats (Assistència sanitària), Humans, Radium

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9578fe4d02c1c74477e8b12ba44cee24
https://doi.org/10.1016/j.ejca.2022.06.057